Immediate Impact
2 from Science/Nature 59 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Development of NK cell-based cancer immunotherapies through receptor engineering
2024 Standout
Works of A. Kelly being referenced
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial
2018
NK Cell immunotherapy for high‐risk neuroblastoma relapse after haploidentical HSCT
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A. Kelly | 172 | 112 | 68 | 98 | 26 | 368 | |
| Sung-Soo Koong | 197 | 107 | 44 | 39 | 19 | 401 | |
| Keiko Kinuya | 92 | 166 | 58 | 59 | 31 | 376 | |
| Alessandra Brofferio | 88 | 170 | 25 | 51 | 28 | 378 | |
| Júlia Fernanda Semmelmann Pereira‐Lima | 180 | 126 | 74 | 157 | 33 | 403 | |
| Michaela Diehl | 170 | 105 | 59 | 90 | 17 | 365 | |
| Jason Sheehan | 134 | 208 | 43 | 162 | 27 | 389 | |
| Yan Zhang | 39 | 70 | 72 | 51 | 30 | 311 | |
| George Samandouras | 65 | 121 | 63 | 107 | 40 | 350 | |
| Andrea Marcadis | 121 | 132 | 23 | 50 | 22 | 407 | |
| G. E. SHAMBAUGH | 60 | 102 | 65 | 46 | 37 | 363 |
All Works
Loading papers...